Organization
SAES Getters SpA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
SAES Getters SpA
... of a 20-to-1 reverse split of its issued and outstanding common stock. SAE's common stock will begin trading on a split-adjusted basis when the market ...
... of a 20-to-1 reverse split of its issued and outstanding common stock. SAE's common stock will begin trading on a split-adjusted basis when the market ...
... Innovate trial results reaffirm Phase 3 protocol design No serious adverse events (SAEs) reported during the Innovate trial Phase 3 pivotal trials for molluscum contagiosum ...
... Kinetics, Inc. (The United States)Qortek, Inc. (The United States)Rubitherm Technologies GmbH (Germany)SAES Getters SpA (Italy)Smart Material Corporation (The United States)Solvay SA (Belgium)Ultimate Niti Technologies, Inc. ...
... preferred stock"), to convert the Series A preferred stock into shares of SAE's common stock on September 5, 2018 pursuant to the terms of the ...
... (3%), pneumonia (3%), major hemorrhage (3%), and actinic keratosis (3%). Serious AEs (SAEs) were seen in 22 patients (33%), with events in five patients (7%) ...
... repeated administrations in the trial. There have been 17 serious adverse events (SAEs) reported, of which nine were reported to be not related or unlikely ...
... (3%), pneumonia (3%), major hemorrhage (3%), and actinic keratosis (3%). Serious AEs (SAEs) were seen in 22 patients (33%), with events in five patients (7%) ...
... confidence interval (CI) 0.41-1.07] and significantly lower rates of serious adverse events (SAEs) [7.1% vs 13.1%; OR 0.51, 95% CI 0.32-0.81] in patients treated with ...
... to placebo, based upon hospitalizations and deaths designated as serious adverse events (SAEs) within 28 days after last dose of study drug. A similar finding ...
Subscribe now for full coverage on SAES Getters SpA
Start My Free Trial